Where Tech Meets Bio

Where Tech Meets Bio

Home
Podcast
Archive
About
AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch
Today, clinical trials are longer and more data-heavy than a decade ago. At a time of regulatory rethinking, we trace how AI is beginning to orchestrate…
 • 
BiopharmaTrend
Weekly Tech+Bio Highlights #40: FDA Sets Deadline for Internal AI Rollout
Also: Foundation Models & Drug‑Discovery Economics, Structuring Meaning for AI with Ontologies, & Emerging Startups
 • 
Roman Kasianov
 and 
BiopharmaTrend
Weekly Tech+Bio Highlights #39: Towards Human-Based Models
Also: AI News, NIH's Policy Shift & What Clinical AI Struggles With
 • 
Roman Kasianov
 and 
BiopharmaTrend
1
Most Popular
View all
Ex-NASA Expert Unveils Everything You Need to Know About Brain-Computer Interfaces
 • Andrii Buvailo
The '4th Wave' of AI Drug Discovery is Here, According to This Report
 • Andrii Buvailo
11 Biopharma Trends to Watch in 2024
 • Andrii Buvailo
13 Foundation Models: Startups, Industry Updates and the Nobel Prize
 • BiopharmaTrend
1
Where Are We Now With AI-driven Drug Discovery?🎄
 • Andrii Buvailo and BiopharmaTrend
2
12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials
 • BiopharmaTrend
30 Companies Leveraging Big Data for Biomedical Progress
Regulatory change and industry demand are fueling a fast-moving market where data-focused companies are key to transforming drug development with more…
 • 
BiopharmaTrend
Weekly Tech+Bio Highlights #38: Predictive Models & Benchmarks
Also: Two-Hour Zebrafish Brain Benchmark, BCI Patent Landscape, & Steering Complex Structure Predictions
 • 
Roman Kasianov
 and 
BiopharmaTrend
Weekly Tech+Bio Highlights #37: Turning Cells Into Language
Also: Who Runs the Tools in AI–Pharma Deals, Four Challenges at the AI-Biology Interface & Industry Highlights
 • 
Roman Kasianov
 and 
BiopharmaTrend
23 New Startups in AI Drug Development Space Launched 2023–2025
A snapshot of emerging startups applying AI across the drug development pipeline—from molecular design to clinical decision support
 • 
BiopharmaTrend
Weekly Tech+Bio Highlights #36: Defining Modern AI Drug Discovery
Also: Neuroscientists Map Cubic Millimeter of Mouse Brain, Moving Away from Animal Testing & Industry Highlights
 • 
Roman Kasianov
 and 
BiopharmaTrend
The Rise of AI Agents in Biotech, Where Are We Now?
A bird's eye view of the emerging field, taking look at several notable academic and commercial examples.
 • 
Andrii Buvailo
 and 
BiopharmaTrend
Weekly Tech+Bio Highlights #35: Reading the Inflection Points of AI Drug Development
Also: Rice-Sized Dissolvable Pacemakers, Foundation Agents, & Industry Highlights
 • 
BiopharmaTrend
 and 
Roman Kasianov
Weekly Tech+Bio Highlights #34
Recent Histology Foundation Model, Agentic AI's, Bringing Touch to VR, and more...
 • 
BiopharmaTrend
 and 
Roman Kasianov
13 Foundation Models: Startups, Industry Updates and the Nobel Prize
From AlphaFold’s Nobel recognition to emerging platforms in drug discovery, genomics, and digital biology—tracking the expanding field of foundation…
 • 
BiopharmaTrend
1
Where Tech Meets Bio
Where Tech Meets Bio
What does the future hold for us in the “century of biotech“?
Recommendations
View all 6
AI Supremacy
AI Supremacy
Michael Spencer
Noahpinion
Noahpinion
Noah Smith
People vs Algorithms
People vs Algorithms
Troy Young
The Algorithmic Bridge
The Algorithmic Bridge
Alberto Romero
The Connected Ideas Project
The Connected Ideas Project
Alexander Titus

Where Tech Meets Bio

AboutArchiveRecommendationsSitemap
© 2025 BiopharmaTrend (BPT Analytics Ltd)
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture